Summary & Overview
HCPCS Level II J0712: Ceftaroline Fosamil Injection, 10 mg
HCPCS Level II code J0712 designates a 10 mg unit of ceftaroline fosamil administered as an injectable antimicrobial. Ceftaroline is a broad-spectrum cephalosporin used for serious bacterial infections where intravenous therapy is indicated. Nationally, accurate coding for parenteral antibiotics like ceftaroline affects hospital and outpatient drug billing, utilization tracking, and payer coverage determinations.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact overview of clinical context, typical sites of service, and the billing use case for unit-based drug codes. The publication provides benchmarking guidance on how J0712 is used in service lines that bill for parenteral antimicrobial therapy, summarizes common payer coverage considerations, and flags where policy updates or prior authorization practices often influence access and reimbursement.
This summary equips billing managers, practice administrators, and policy analysts with a concise reference to the code’s clinical purpose, payer landscape, and the kinds of documentation and service settings most commonly associated with J0712. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J0712 represents an injection of ceftaroline fosamil, 10 mg. This code denotes the administration of the antimicrobial agent ceftaroline fosamil in a specified 10 mg unit.
Service Type: Drug administration / Parenteral antimicrobial therapy
Typical Site of Service: Infusion center, outpatient clinic, hospital inpatient or outpatient department, or physician office
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old hospitalized patient with community-acquired pneumonia that is not responding to first-line beta-lactam therapy is ordered to receive intravenous ceftaroline fosamil. The patient presents with fever, productive cough, hypoxia requiring supplemental oxygen, and imaging consistent with lobar consolidation. Cultures are pending; Gram-positive cocci suspected. Pharmacy prepares J0712 dosed per weight and renal function, and the inpatient infusion nursing team administers the injection via IV piggyback or central line. Documentation includes indication, dose (number of J0712 units given), route, time, patient tolerance, and any infusion-related reactions. Typical workflow steps: order entry (physician), pharmacy verification and reconstitution, bedside nurse administration, and progress notes documenting clinical response and adverse events. Ambulatory infusion centers may also administer J0712 for complicated skin and skin structure infections or pneumonia in outpatient parenteral antibiotic therapy (OPAT) programs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no special modifier applies |